| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0070986 | BP | left/right axis specification | The establishment, maintenance and elaboration of the left/right axis. The left/right axis is defined by a line that runs orthogonal to both the anterior/posterior and dorsal/ventral axes. Each side is defined from the viewpoint of the organism rather of the observer (as per anatomical axes). |
NOTCH1, AHI1, MNS1, SETDB2, PITX2, CITED2, HSPB11 |
GO:0070987 | BP | error-free translesion synthesis | The conversion of DNA-damage induced single-stranded gaps into large molecular weight DNA after replication by using a specialized DNA polymerase or replication complex to insert a defined nucleotide across the lesion. This process does not remove the replication-blocking lesions but does not causes an increase in the endogenous mutation level. For S. cerevisiae, RAD30 encodes DNA polymerase eta, which incorporates two adenines. When incorporated across a thymine-thymine dimer, it does not increase the endogenous mutation level. |
UBC, PCNA, RPA3, RFC4, RFC2, RFC5, RFC3, VCP, RPS27A, UBA52, UFD1L, POLH |
GO:0070988 | BP | demethylation | The process of removing one or more methyl groups from a molecule. |
CYP1A1, CYP51A1 |
GO:0070989 | BP | oxidative demethylation | The process of removing one or more methyl groups from a molecule, involving the oxidation (i.e. electron loss) of one or more atoms in the substrate. |
CYP3A4, CYP2D6, CYP2C9, CYP3A5, ALKBH1, FTO |
GO:0070994 | BP | detection of oxidative stress | The series of events in which a stimulus indicating oxidative stress is received and converted into a molecular signal. |
ADIPOQ |
GO:0070995 | BP | NADPH oxidation | A metabolic process that results in the oxidation of reduced nicotinamide adenine dinucleotide, NADPH, to the oxidized form, NADP. |
FMO2 |
GO:0070997 | BP | neuron death | The process of cell death in a neuron. |
DPYSL4, NLRP5, MAGI1, BAG5 |
GO:0071000 | BP | response to magnetism | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnetic stimulus. |
TJP1 |
GO:0071025 | BP | RNA surveillance | The set of processes involved in identifying and degrading defective or aberrant RNAs. |
PELO |
GO:0071028 | BP | nuclear mRNA surveillance | The set of processes involved in identifying and degrading defective or aberrant mRNAs within the nucleus. |
DXO, EXOSC9, EXOSC7, EXOSC6, XRN1, EXOSC8, EXOSC4 |
GO:0071034 | BP | CUT catabolic process | The chemical reactions and pathways resulting in the breakdown of cryptic unstable transcripts (CUTs). |
EXOSC2, EXOSC3, DIS3 |
GO:0071035 | BP | nuclear polyadenylation-dependent rRNA catabolic process | The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of a ribosomal RNA (rRNA) molecule, including RNA fragments released as part of processing the primary transcript into multiple mature rRNA species, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target rRNA. |
EXOSC9, EXOSC2, EXOSC7, EXOSC8, EXOSC3 |
GO:0071038 | BP | nuclear polyadenylation-dependent tRNA catabolic process | The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of an aberrant or incorrectly modified transfer RNA (tRNA) molecule, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target tRNA. |
EXOSC9, EXOSC2, EXOSC7, EXOSC8, EXOSC3 |
GO:0071042 | BP | nuclear polyadenylation-dependent mRNA catabolic process | The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of a messenger RNA (mRNA) molecule, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target mRNA. |
EXOSC9, EXOSC7, PNPT1, EXOSC8 |
GO:0071044 | BP | histone mRNA catabolic process | The chemical reactions and pathways resulting in the breakdown of histone messenger RNA (mRNA). |
PAPD4, DCP2, XRN1, PAPD5, EXOSC4, MTPAP |
GO:0071048 | BP | nuclear retention of unspliced pre-mRNA at the site of transcription | The process involved in retention of incorrectly or incompletely spliced pre-mRNA within the nucleus at the site of transcription. |
PRPF18 |
GO:0071049 | BP | nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription | The process involved in retention of mRNAs that have incorrectly formed 3'-ends within the nucleus at the site of transcription. |
EXOSC2, EXOSC3 |
GO:0071051 | BP | polyadenylation-dependent snoRNA 3'-end processing | Any process involved in forming the mature 3' end of a snoRNA molecule linked to prior polyadenylation of the 3'-end of the precursor snoRNA. |
EXOSC2, EXOSC6, EXOSC4, EXOSC3 |
GO:0071071 | BP | regulation of phospholipid biosynthetic process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids. |
IDH1 |
GO:0071072 | BP | negative regulation of phospholipid biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids. |
SLC27A1 |
GO:0071073 | BP | positive regulation of phospholipid biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids. |
FABP3 |
GO:0071103 | BP | DNA conformation change | A cellular process that results in a change in the spatial configuration of a DNA molecule. A conformation change can bend DNA, or alter the, twist, writhe, or linking number of a DNA molecule. |
HHEX |
GO:0071104 | BP | response to interleukin-9 | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-9 stimulus. |
JAK3, CITED1 |
GO:0071105 | BP | response to interleukin-11 | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-11 stimulus. |
CITED1 |
GO:0071107 | BP | response to parathyroid hormone | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a parathyroid hormone stimulus. |
PTH, ITGA2, CITED1 |
GO:0071108 | BP | protein K48-linked deubiquitination | A protein deubiquitination process in which a K48-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is removed from a protein. |
USP27X, TNFAIP3, ATXN3, OTUD7B, USP34, BAP1, OTUB2, OTUB1, VCPIP1, USP25, USP20 |
GO:0071109 | BP | superior temporal gyrus development | The process whose specific outcome is the progression of the superior temporal gyrus over time, from its formation to the mature structure. The superior temporal gyrus is a portion of the cerebral cortex that extends from the lateral sulcus to the superior temporal sulcus. |
GSK3B |
GO:0071139 | BP | resolution of recombination intermediates | The cleavage and rejoining of intermediates, such as Holliday junctions, formed during DNA recombination to produce two intact molecules in which genetic material has been exchanged. |
SMC5, SMC6 |
GO:0071156 | BP | regulation of cell cycle arrest | Any process that modulates the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases. |
BIN1, AKT2, CDK5, FOXM1 |
GO:0071157 | BP | negative regulation of cell cycle arrest | Any process that decreases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases. |
MDM4, CDK4, MIF, MDM2, ZNF268, GPER1 |
GO:0071158 | BP | positive regulation of cell cycle arrest | Any process that increases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases. |
TGFB1, TP53, PRKACA, BRCA1, HMGA2, FOXO4, INSM1, ID2, PKD2, PPP2R5B, CRLF3, GATA6, UHRF2, MYBBP1A, RGCC |
GO:0071166 | BP | ribonucleoprotein complex localization | Any process in which a ribonucleoprotein complex is transported to, or maintained in, a specific location within a cell. |
PRPF31 |
GO:0071168 | BP | protein localization to chromatin | Any process in which a protein is transported to, or maintained at, a part of a chromosome that is organized into chromatin. |
RAD21, ESR1, PLK1, EZH2, ESCO2, WAPL |
GO:0071169 | BP | establishment of protein localization to chromatin | The directed movement of a protein to a part of a chromosome that is organized into chromatin. |
H2AFY, SGF29, H2AFY2, LRWD1, RUVBL2 |
GO:0071171 | BP | site-specific DNA replication termination at RTS1 barrier | A DNA replication termination process that takes place at the RTS1 termination site in the mating type locus, in a specific direction required for subsequent imprinting and mating-type switching. |
RTFDC1 |
GO:0071173 | BP | spindle assembly checkpoint | A cell cycle checkpoint that delays the metaphase/anaphase transition until the spindle is correctly assembled and chromosomes are attached to the spindle. |
BUB1, BUB3, CASC5 |
GO:0071205 | BP | protein localization to juxtaparanode region of axon | Any process in which a protein is transported to, or maintained at, the juxtaparanode region of an axon. |
EPB41L3 |
GO:0071218 | BP | cellular response to misfolded protein | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a misfolded protein stimulus. |
ATXN3, UBE2W, HDAC6, STUB1 |
GO:0071219 | BP | cellular response to molecule of bacterial origin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin. |
SIRT2 |
GO:0071221 | BP | cellular response to bacterial lipopeptide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bacterial lipopeptide stimulus. |
TLR2, TIRAP |
GO:0071222 | BP | cellular response to lipopolysaccharide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
TLR4, TLR5, ABCA1, ASS1, SERPINE1, IL6, ICAM1, CD14, GSTP1, CXCL8, TFPI, CCL2, CD36, CEBPB, XBP1, NFKB1, TNFRSF1B, NR1D1, TNFAIP3, IL10, MRC1, TNFSF4, HMGB2, ZFP36, IL12A, TSPO, WNT5A, MAPK8, STAR, B2M, CCL20, HAMP, HSF1, PPARD, RELA, MEF2C, PDE4D, NR1H3, ADAM9, ANKRD1, MAPK14, CMPK2, PABPN1, LILRB1, NR1H4, LITAF, VIMP, SPON2, CDK19, CXCL16, PLSCR4, NFKBIL1, PPARGC1A, SHPK, PYCARD, HDAC5 |
GO:0071223 | BP | cellular response to lipoteichoic acid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipoteichoic acid stimulus; lipoteichoic acid is a major component of the cell wall of gram-positive bacteria and typically consists of a chain of glycerol-phosphate repeating units linked to a glycolipid anchor. |
TLR4, RIPK2, TLR2, CD14, CD36, TIRAP, CCL20 |
GO:0071224 | BP | cellular response to peptidoglycan | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptidoglycan stimulus. Peptidoglycan is a bacterial cell wall macromolecule. |
RIPK2 |
GO:0071225 | BP | cellular response to muramyl dipeptide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan. |
RIPK2, ARHGEF2, PTPN22 |
GO:0071226 | BP | cellular response to molecule of fungal origin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of fungal origin such as chito-octamer oligosaccharide. |
SYK, CLEC7A |
GO:0071228 | BP | cellular response to tumor cell | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a tumor cell. |
TXNIP |
GO:0071230 | BP | cellular response to amino acid stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups. |
IPO5, SOCS1, EGFR, ASS1, TNF, COL1A1, COL3A1, COL5A2, COL1A2, MMP2, COL6A1, CEBPB, XBP1, DNMT1, ZEB1, SESN2, SESN3, COL16A1, HNRNPD, NTRK2, CPEB4, LAMTOR1, NSMF, SLC38A9, CPEB3, PDGFD, RRAGC, RRAGD, PDGFC, SH3BP4, LAMTOR3, LAMTOR2, SESN1 |
GO:0071231 | BP | cellular response to folic acid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a folic acid stimulus. |
FOLR1 |
GO:0071233 | BP | cellular response to leucine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leucine stimulus. |
SESN2, UBR1 |
GO:0071236 | BP | cellular response to antibiotic | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms. |
HSPA5, CDKN1B, PLA2G4A, STAR, MDM2 |
GO:0071242 | BP | cellular response to ammonium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ammonium ion stimulus. |
ASS1 |
GO:0071243 | BP | cellular response to arsenic-containing substance | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an arsenic stimulus from compounds containing arsenic, including arsenates, arsenites, and arsenides. |
DDX3X, HMOX1, PPIF, GSTO1, CPEB2, GSTO2, MKNK2 |
GO:0071247 | BP | cellular response to chromate | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chromate stimulus. |
BAD |
GO:0071248 | BP | cellular response to metal ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus. |
HSD17B1 |
GO:0071250 | BP | cellular response to nitrite | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrate stimulus. |
PPARGC1A |
GO:0071257 | BP | cellular response to electrical stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus. |
ADSS, NSMF, ADSSL1 |
GO:0071258 | BP | cellular response to gravity | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gravitational stimulus. |
PTAFR |
GO:0071259 | BP | cellular response to magnetism | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnetic stimulus. |
ASCL1 |
GO:0071260 | BP | cellular response to mechanical stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
TLR4, CHEK1, TLR3, TLR5, BCL10, EGFR, AGT, TGFB1, IL1B, COL1A1, IRF1, ITGA2, GJA1, NFKB1, MAG, BMP6, GADD45A, FAS, MAPK3, TNFRSF8, CASP1, AKT1, PTGS2, PTGER4, LTBR, MAPK8, SOX9, GCLC, ATP1A2, HDAC4, MTPN, RAC1, CRADD, BNIP3, FADD, CASP8, ANKRD1, HABP4, BAD |
GO:0071264 | BP | positive regulation of translational initiation in response to starvation | Any process that activates or increases the frequency, rate or extent of translation initiation, as a result of deprivation of nourishment. |
EIF2AK4, IMPACT |
GO:0071266 | BP | de novo' L-methionine biosynthetic process | The chemical reactions and pathways resulting in the formation of L-methionine, the L-enantiomer of (2S)-2-amino-4-(methylsulfanyl)butanoic acid, from simpler components. |
CTH |
GO:0071268 | BP | homocysteine biosynthetic process | The chemical reactions and pathways resulting in the formation of homocysteine, 2-amino-4-sulfanylbutanoic acid. |
AHCY |
GO:0071276 | BP | cellular response to cadmium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. |
MT1E, MT1F, CYBB, HMOX1, MT1G, MT3, AKR1C3, STAR, MT1H, MT1X |
GO:0071277 | BP | cellular response to calcium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
RASA4, FOS, EDN1, JUN, ALOX15, JUNB, JUND, CAPN3, SYT1, PPIF, FUS, WNT5A, AKR1C3, IQGAP1, FOSB, GPLD1, MEF2A, MEF2C, CAMK2D, RYR3, RASGRP2, CPNE2, SLC25A23, ECT2, CACYBP |
GO:0071279 | BP | cellular response to cobalt ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cobalt ion stimulus. |
SERPINF1, BNIP3 |
GO:0071280 | BP | cellular response to copper ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus. |
PRNP, MT1G, SNCA, AQP2 |
GO:0071281 | BP | cellular response to iron ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus. |
TF, BMP6, B2M, HFE, TFR2 |
GO:0071283 | BP | cellular response to iron(III) ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron(III) ion stimulus. |
CCNB1 |
GO:0071284 | BP | cellular response to lead ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lead ion stimulus. |
ALAD |
GO:0071285 | BP | cellular response to lithium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus. |
FABP4, FAS, CALR, CDKN1B, ID2, XRCC4, NFATC4, TPH2 |
GO:0071286 | BP | cellular response to magnesium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus. |
FBP1, KCNA1, ANK3, RYR3 |
GO:0071287 | BP | cellular response to manganese ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a manganese ion stimulus. |
PARK2, TH, HSPA5, ATP13A2 |
GO:0071288 | BP | cellular response to mercury ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus. |
AQP2 |
GO:0071294 | BP | cellular response to zinc ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus. |
KCNK3, MT2A, MT1E, MT1F, PARP1, MT1G, CREB1, TSPO, MT1H, MT1X, ZNF658, MT1M, ATP13A2 |
GO:0071298 | BP | cellular response to L-ascorbic acid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-ascorbic acid (vitamin C) stimulus. |
LEP |
GO:0071300 | BP | cellular response to retinoic acid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. |
OGT, HOXA2, TBX1, KLF4, BRINP1, FZD7, ALDH1A2, ABCA1, COL1A1, LYN, WNT2, CCL2, KRT13, TNC, EPHA3, LTK, PCK1, SERPINF1, PPARG, LEP, WNT5A, ABL2, YAP1, SOX9, WNT3, MEF2C, PTK7, TEAD2, TWF2, ADNP2, SETX, KMT2E, OSR1, HDAC2, WNT5B, CYP26B1, NDUFA13, FZD4, WNT6 |
GO:0071301 | BP | cellular response to vitamin B1 | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B1 stimulus. |
MDM2 |
GO:0071305 | BP | cellular response to vitamin D | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus. |
PENK, BGLAP, ATP2B1, TNC, SFRP1 |
GO:0071306 | BP | cellular response to vitamin E | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin E stimulus. |
COL1A1, PPARG |
GO:0071307 | BP | cellular response to vitamin K | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin K stimulus. |
GAS6, POSTN |
GO:0071310 | BP | cellular response to organic substance | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus. |
IL1B, CLEC3B, PSAP, BCL2, EGR2, CASP1, CD68, TIMP3, IQGAP3 |
GO:0071312 | BP | cellular response to alkaloid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active. |
ICAM1, STAR, MDM2, TRPV1 |
GO:0071313 | BP | cellular response to caffeine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a caffeine stimulus. Caffeine is an alkaloid found in numerous plant species, where it acts as a natural pesticide that paralyzes and kills certain insects feeding upon them. |
GSTM2, RYR3, RYR2, SEPN1, PPARGC1A |
GO:0071314 | BP | cellular response to cocaine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant. |
CCNA2 |
GO:0071316 | BP | cellular response to nicotine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus. |
TNF, NTRK1, TH, NFKB1, RELA, KCNJ11, BAD |
GO:0071318 | BP | cellular response to ATP | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus. |
CCL2, HSP90B1, PTGS2, RYR3, TRPV1, P2RX4 |
GO:0071320 | BP | cellular response to cAMP | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus. |
AQP9, KDM1A, AQP8, ASS1, PENK, APP, RPLP0, CFTR, EZR, SRD5A1, WT1, IGFBP5, PTAFR, PCK1, PIK3CG, STAR, STC1, RAP1A, ZFP36L1, AKAP6, RAPGEF1, ITPR2, ADIPOQ, SLC5A5, INPP5K, NOX4 |
GO:0071321 | BP | cellular response to cGMP | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cGMP (cyclic GMP, guanosine 3',5'-cyclophosphate) stimulus. |
PDE3A |
GO:0071322 | BP | cellular response to carbohydrate stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbohydrate stimulus. |
PRKCB, RPS6KA2 |
GO:0071332 | BP | cellular response to fructose stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fructose stimulus. |
XBP1, SLC2A5, PCK1, PPARGC1A |
GO:0071333 | BP | cellular response to glucose stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus. |
FOXO3, ERN1, ICAM1, TH, LGALS1, NME1, PRKACA, XBP1, NME2, SERPINF1, PIK3CA, GATA4, GCLC, GCLM, STAR, POLG, UCP2, RAP1A, RACK1, MEF2C, SOX4, TJP1, PPP3CA, GAS6, KCNJ11, PCK2, AACS, CPB2, PEO1, GPER1, SLC29A1, NOX4, PPARGC1A, ZNF236, IRS2 |
GO:0071338 | BP | positive regulation of hair follicle cell proliferation | Any process that activates or increases the rate or extent of hair follicle cell proliferation. |
CDC42 |
GO:0071340 | BP | skeletal muscle acetylcholine-gated channel clustering | The accumulation of acetylcholine-gated cation channels in a narrow, central region of muscle fibers, in apposition to nerve terminals. |
MUSK, ETV5, COLQ |
GO:0071344 | BP | diphosphate metabolic process | The chemical reactions and pathways involving diphosphate, the anion or salt of diphosphoric acid. |
PPA2 |
GO:0071345 | BP | cellular response to cytokine stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus. |
HAX1, CSF1R, MME, HCLS1, CXCR4, AKAP6, DPYSL3, PID1, KHSRP |
GO:0071346 | BP | cellular response to interferon-gamma | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far. |
TLR3, DAPK3, SYNCRIP, ASS1, GAPDH, EDN1, EPRS, CCL3, CCL4, TDGF1, CCL2, CCL5, CD58, HLA-DPA1, MRC1, RPL13A, WNT5A, IL12RB1, STAR, DAPK1, CCL20, CCL8, GBP6 |
GO:0071347 | BP | cellular response to interleukin-1 | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
FGB, IL6, EDN1, ICAM1, CXCL8, CCL3, TFPI, CCL4, CCL2, CCL5, CEBPB, NFKB1, YY1, RORA, PCK1, CHI3L1, RBMX, SOX9, ADAMTS12, CCL20, CCL8, RELA, HYAL2, ANKRD1, PTGIS, HIF1A, SFRP1, HAS2, TANK, OTUB1, ADAMTS7, PYCARD, KLF2 |
GO:0071352 | BP | cellular response to interleukin-2 | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-2 stimulus. |
CDC5L |
GO:0071353 | BP | cellular response to interleukin-4 | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus. |
RPLP0, HSP90AB1, HSPA5, ALAD, XBP1, MRC1, CORO1A, FASN, MCM2, TUBA1B, NFIL3, SHPK |
GO:0071354 | BP | cellular response to interleukin-6 | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-6 stimulus. |
TDGF1, CCL2, NFKB1, PHB, HAMP, RELA, SELPLG, PTGIS, PID1, PPARGC1A, ST3GAL6 |